The results showed that CD8+ T cells from mice treated with gCpG + OVA couldn’t inhibit B16-F10 melanoma, indicated that gCpG + OVA induced CD8+ T cell response was OVA-specific (Fig. 5c). This evidence concerns the gene CD8A and melanoma.